Guideline summarizes evidence on nebulization management for nasal high-flow oxygen therapy
This is a guideline that synthesizes 13 evidence sources, including one clinical decision, two guidelines, one team standard, seven expert consensuses, and two evidence summaries, to address nebulization management for adult patients on nasal high-flow oxygen therapy. The authors report that evidence levels ranged from Level 1 to Level 5, with recommendation grades including A (strong) and B (weak). Quality appraisal using AGREE II showed all three guidelines or standards scored above 60% across all domains, and most items in the seven expert consensuses were rated positively.
The guideline does not report a specific study population, intervention comparator, primary outcome, follow-up period, or safety data. It provides a structured compilation of current best practices to serve as a practical reference to guide the nebulization process. The authors note this compilation is based on existing guidelines and consensuses, not new trial data.
Limitations include the absence of reported safety data and the reliance on a mix of evidence types, which may vary in rigor. The practice relevance is framed as a reference tool for clinicians, with the understanding that the evidence is a synthesis of existing recommendations rather than a primary trial.